natgillin/translations-raw huggingface dataset:
The probability of survival at 1 year was 97%, at 2 years 94% and at 3 years 88%.
Verjetnost preživetja po enem letu je bila 97 %, po dveh letih 94 %, in po treh letih 88 %.
The probability to require only one treatment with Ameluz and remain completely cleared 12 months later was 34.5% on average with all lamps.
Verjetnost, da bolnik potrebuje samo eno zdravljenje z zdravilom Ameluz in ostane povsem čist tudi 12 mesecev kasneje, je bila povprečno 34,5-odstotna pri uporabi vseh vrst svetilk.
The problem will usually go away but if it doesn’t, check with your doctor or pharmacist.
Težava ponavadi izgine, v nasprotnem primeru pa se posvetujte s svojim zdravnikom ali farmacevtom.
The product (cartridges in-use in the pump) may be stored for a maximum of 2 weeks.
Zdravilo (vložke, ki so v uporabi v črpalki), lahko shranjujete največ dva tedna.
The product can be re-activated up to 48 hours after initial activation and used up to 12 hours after the second activation, whether stored under refrigeration or at room temperature.
Reaktivirate ga lahko do 48 ur po prvem aktiviranju in ga uporabite do 12 ur po drugem aktiviranju, ne glede na to, ali je shranjen v hladilniku ali pri sobni temperaturi.
The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
To zdravilo se lahko uporablja kot del strategije zdravljenja dermatitisa zaradi alergije na bolhe (FAD).
The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
Zdravilo je del zdravljenja in preprečevanja alergijskih dermatitisov, ki jih povzroča bolhavost (FAD).
The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
Zdravilo je lahko del strategije zdravljenja in preprečevanja alergijskih dermatitisov, ki jih povzroča bolhavost (FAD).
The product can be used in chickens laying eggs for human consumption as it has been shown to have no adverse effects on egg formation or the laying process at the recommended treatment dose.
Zdravilo se lahko uporablja pri piščancih, katerih jajca so namenjena prehrani ljudi, saj zdravilo v priporočenem odmerku ni povzročilo nobenih negativnih učinkov na nastanek jajc ali postopek valjenja.
The product contains 100 International Units (IU) per ml (500 IU/5 ml or 1000 IU/10 ml) human coagulation factor IX when reconstituted with 5 ml or 10 ml, respectively, of water for injections.
Zdravilo vsebuje 100 mednarodnih enot (i.e.) na ml (500 i.e./5 ml ali 1000 i.e./10 ml) humanega koagulacijskega faktorja IX, po rekonstituciji s 5 ml oziroma 10 ml vode za injekcije.
The product contains less than 1 mmol (39 mg) potassium per administration of 27-60 injection sites ; i.e. essentially potassium-free.
Zdravilo vsebuje manj kot 1 mmol (39 mg) kalija na uporabo na 27–60 mestih injiciranja, tj. je skoraj brez kalija.
The product contains traces of mouse proteins.
Izdelek vsebuje sledove mišjih beljakovin.
The product contributes towards the control of environmental flea populations in areas to which treated cats have access.
Zdravilo prispeva k obvladovanju okoljske populacije bolh na področjih, kamor imajo dostop zdravljene mačke.
The product contributes towards the control of environmental flea populations in areas to which treated dogs have access.
Zdravilo prispeva k obvladovanju okoljske populacije bolh na področjih, kamor imajo pristop zdravljeni psi.
The product contributes towards the control of environmental flea populations in areas to which treated dogs have access.
Zdravilo prispeva k obvladovanju okoljske populacije bolh na področjih, kamor imajo psi pristop.
The product contributes towards the control of the environmental flea populations in areas to which treated dogs have access.
Zdravilo prispeva k obvladovanju okoljske populacije bolh na področjih, kamor imajo psi dostop.
The product diluted in 0.9% sodium chloride intravenous solution will retain chemical stability if stored up to 24 hours at 2°C and 8°C under protection from light; but microbiological safety will depend on the reconstitution and dilution having been performed aseptically.
Z 0,9 % raztopino natrijevega klorida za intravensko uporabo razredčeno zdravilo je kemično stabilno 24 ur pri temperaturi od 2 do 8ºC in zaščiteno pred svetlobo; mikrobiološka neoporečnost zdravila pa zavisi od uporabe aseptične tehnike pri pripravi in redčenju raztopine.
The product has a long duration of action; however, the exact clinical effect duration after a single injection is unknown.
Zdravilo ima dolgotrajno delovanje, vendar točno trajanje delovanja po enkratnem odmerku ni znano.
The product has been shown to be stable to the pelleting process at temperatures of 75 °C. Aggressive pelleting conditions such as temperatures in excess of 80 °C, and the use of abrasive substances for pre- mixture should be avoided.
Zdravilo je stabilno v procesu peletiranja pri temperaturi 75°C. Izogibajte se agresivnim postopkom peletiranja, kot sta temperatura nad 80°C in uporaba abrazivnih substanc za predmešanice.
The product has been shown to be stable to the pelleting process at temperatures of 75 °C. Aggressive pelleting conditions such as temperatures in excess of 80 °C, and the use of abrasive substances for pre-mixture should be avoided.
Zdravilo je stabilno v procesu peletiranja pri temperaturi 75°C. Izogibajte se agresivnim postopkom peletiranja, kot sta temperatura nad 80°C in uporaba abrazivnih substanc za predmešanice.
The product has been used in combination with phenobarbital in a small number of cases and no harmful clinical interactions were observed.
Zdravilo so pri majhnem številu primerov uporabili v kombinaciji s fenobarbitalom, vendar neželenih kliničnih interakcij niso opazili.
The product information (Sections 4.4 and 4.8 of the SmPC) provides already information on clinical trial results in which showed an increased fracture risk in women only.
Informacije o zdravilu (poglavji 4.4 in 4.8 Glavnih značilnosti zdravila) že zagotavljajo informacije o rezultatih kliničnih preskušanj, ki so pokazali povečano tveganje zloma samo pri ženskah.
The product information of UNISTRAIN PRRS should be consulted before administration of the mixed products.
Preden živali injicirate mešanico zdravil, preberite informacije o cepivu UNISTRAIN PRRS.
The product information of UNISTRAIN PRRS should be consulted before administration of the mixed products.
Preden živali injicirate mešanico zdravil, preberite informacije o cepivuUNISTRAIN PRRS.
The product is a clear, colourless to pale yellow solution for injection containing 15 mg pegbovigrastim (pegylated bovine colony stimulating factor) in a pre-filled syringe.
Zdravilo je bistra brezbarvna do bledorumena raztopina za injiciranje v napolnjeni injekcijski brizgi, ki vsebuje 15 mg pegbovigrastima (pegiliranega faktorja, ki spodbuja nastajanje kolonij govejih granulocitov).
The product is available in a single pack of either 5 ml or 20 ml, composed of a vial containing the freeze- dried powder, and a second vial containing the diluent.
Zdravilo je na voljo v posameznem pakiranju z eno 5- ali 20-mililitrsko vialo, ki vsebuje liofiliziran prašek, in eno vialo z vehiklom.
The product is available in different sizes and comes in packages with up to 5 units: Package with 1 matrix of 9.5 cm x 4.8 cm
Zdravilo je na voljo v različnih velikostih in pakiranjih, ki vsebujejo do največ 5 enot: Pakiranje z 1 matriksom velikosti 9,5 cm x 4,8 cm
The product is for skin application on dogs only; do not put in your dog’s mouth.
To zdravilo se uporablja samo za pse za nanos na kožo, ne dajajte ga psu v gobec.
The product is given as an injection in the neck just behind the ear.
Cepivo se daje v obliki injekcije v vrat, tik za ušesom.
The product is made from human plasma (the liquid part of the blood) and contains the active substances called human coagulation factor VIII (FVIII) and human von Willebrand factor (VWF).
Zdravilo je narejeno iz človeške plazme (tekoči del krvi) in vsebuje zdravilni učinkovini humani koagulacijski faktor VIII (FVIII) in humani von Willebrandov faktor (VWF).
The product is not intended to be stored after dilution unless the dilution has taken place under controlled and validated aseptic conditions.
Zdravilo ni namenjeno shranjevanju po razredčitvi, razen če je razredčitev
The product is now ready for injection.
Zdravilo je zdaj pripravljeno za injiciranje.
The product is now ready for use.
Zdravilo je zdaj pripravljeno za uporabo.
The product is produced from colostrum collected from cows kept under field conditions.
Zdravilo je proizvedeno iz kolostruma krav, ki se vzrejajo v terenskih pogojih.
The product is reconstituted using the vial adapter included.
Za pripravo zdravila uporabite priloženi nastavek za vialo.
The product is supplied as 1 vial of 3 ml and 5 vials of 3 ml.
Kontrastno sredstvo je na voljo v naslednjih velikostih pakiranja: 1 viala po 3 ml in 5 vial po 3 ml.
The product is to be used only when all three groups of parasites are targeted at the same time.
Zdravilo se sme uporabiti samo, ko je namen zdravljenja sočasno usmerjen na vse tri skupine parazitov.
The product kills fleas before egg production and therefore prevents household contamination.
Zdravilo ubije bolhe preden lahko izležejo jajčeca, zato preprečuje kontaminacijo okolice za razvojnimi oblikami bolh.
The product literature of Porcilis M Hyo ID ONCE should be consulted.
Preučiti je treba podatke za Porcilis M Hyo ID ONCE.
The product may be administered throughout the year or at least 1 month before the first expected exposure to mosquitoes.
Morda bomo morali zdravilo nanašati vse leto, vendar ga moramo aplicirati najmanj en mesec pred pričakovano izpostavljenostjo komarjem.
The product may be administered throughout the year or at least 1 month before the first expected exposure to mosquitoes.
Morda bomo morali zdravilo nanašati vse leto, vendar ga moramo belemu dihurju aplicirati najmanj en mesec pred pričakovano izpostavljenostjo komarjem.
The product may be administered throughout the year or at least 1 month before the first expected exposure to mosquitoes.
Morda bomo morali zdravilo nanašati vse leto, vendar ga moramo mački aplicirati najmanj en mesec pred pričakovano izpostavljenostjo komarjem.
The product may be administered throughout the year or at least 1 month before the first expected exposure to mosquitoes.
Morda bomo morali zdravilo nanašati vse leto, vendar ga moramo psu aplicirati najmanj en mesec pred pričakovano izpostavljenostjo komarjem.
The product may be kept for a total of
Zdravilo lahko shranjujete največ
The product may be stored at 25 °C for 24 hours maximum.
Zdravilo lahko pri temperaturi 25°C hranite največ 24 ur.
The product may be stored for a maximum of 4 weeks below 25°C away from direct heat or direct light.
Zdravilo lahko shranjujete največ 4 tedne pri temperaturi do 25 °C zaščiteno pred neposredno toploto ali svetlobo.
The product may be stored for a maximum of 4 weeks below 25°C. Do not refrigerate.
Zdravilo lahko shranjujete največ 4 tedne pri temperaturi do 25 °C. Ne shranjujte v hladilniku.
The product may be stored for a maximum of 4 weeks below 30°C. Do not refrigerate.
Zdravilo se shranjuje največ 4 tedne na temperaturi do 30 °C. Ne shranjujte v hladilniku.
The product may lessen signs and symptoms of acute infection delaying the diagnosis
Zdravilo lahko oslabi znake in simptome akutne okužbe in podaljša čas do diagnoze;
The product must also not be used in cases of hypersensitivity (allergy) to either of the active substances or to any of the other ingredients.
Zdravilo se prav tako ne sme uporabljati, če je pes preobčutljiv za (alergičen na) katero od zdravilnih učinkovin ali katero koli drugo sestavino zdravila.
The product must be aseptically withdrawn through the stopper using sterilised single-use needle and syringe after disinfecting the stopper.
Po dezinfekciji zaporke je treba izdelek z uporabo sterilne igle in brizge za enkratno uporabo aseptično odvzeti skozi zaporko.
The product must be brought to room or body temperature before use.
Pred uporabo morate zdravilo segreti na sobno ali telesno temperaturo.
The product must be examined before use to confirm that all solids are dissolved and that the container and closure are un-damaged.
Pred uporabo morate zdravilo pregledati in se prepričati, da so se vse trdne snovi raztopile in da sta posoda in pokrov nepoškodovana.
The product must be reconstituted, administered and handled with caution using aseptic technique to maintain product sterility.
Zdravilo je treba rekonstituirati, dati in z njim ravnati previdno, z uporabo aseptične tehnike, da se ohrani sterilnost zdravila.
The product must not be administered if any cloudiness, lumps or particulate matter are visible.
Če so vidne motnjave, grudice ali trdni delci, izdelka ne smete uporabiti.
The product must not be given to patients with active or suspected infection
Zdravila se ne sme dajati bolnikom z aktivno okužbo ali pri sumu na okužbo.
The product must only be used with a safety device including a needle guard and a mechanism to prevent accidental operation of the trigger.
Zdravilo uporabljajte samo z varnostnim pripomočkom, opremljenim z varovalom za iglo, in sistemom, ki preprečuje naključno delovanje sprožilca.
The product provides repellent (anti-feeding) activity against ticks and various insect species, preventing the repelled parasite from taking a blood meal and thus reducing the risk of disease transmission.
Zdravilo ima repelentno delovanje (preprečevanje hranjenja) proti klopom in različnim vrstam insektov, s tem da parazitu prepreči, da bi se hranil s krvjo in tako zmanjšuje tveganje prenašanja bolezni.
The product should be added to a volume of water that the chickens will consume in one day.
Izdelek dodajte količini vode, ki jo bodo piščanci lahko zaužili v enem dnevu.
The product should be added to a volume of water that the pigs will consume in one day.
Izdelek dodajte količini vode, ki jo bodo prašiči popili v enem dnevu.
The product should be added to a volume of water that the turkeys will consume in one day.
Zdravilo dodajte količini vode, ki jo bodo purani lahko zaužili v enem dnevu.
The product should be administered at a dose of 2.7–6.9 mg/kg bodyweight in accordance with the following table:
Zdravilo uporabljajte v odmerku 2,7–6,9 mg/kg telesne teže, glede na spodnjo tabelo:
The product should be administered immediately after thawing.
Zdravilo uporabite takoj po odtajanju.
The product should be administered monthly.
Zravilo dajemo mesečno.
The product should be administered neat or diluted in milk or in milk replacer within the first 12 hours of the calf’s life, preferably, as soon as it is receptive.
Zdravilo dajemo nerazredčeno ali razredčeno z mlekom ali mlečnim nadomestkom v prvih 12 urah po rojstvu.
The product should be administered neat or diluted in milk or in milk replacer within the first 12 hours of the calf’s life, preferably, as soon as it is receptive.
Zdravilo dajemo nerazredčeno ali razredčeno z mlekom ali mlečnim nadomestkom v prvih 12 urah po telitvi.
The product should be administered onto the oral mucosa between dog’s cheek and gum at a dose of 125 micrograms/m2.
Zdravilo se daje na ustno sluznico med lice in dlesen psa v odmerku 125 mikrogramov/m2.
The product should be administered via the intravenous route.
Zdravilo dajte intravensko.
The product should be administered within 4 hours after the last milking.
Zdravilo dajte znotraj 4 ur po zadnji molži.
The product should be applied on cats up to 6.25 kg body weight in one spot at the base of the skull and in two spots on cats greater than 6.25 kg bodyweight.
Zdravilo dajte mačkam, ki tehtajo do 6,25 kg na eno mesto oz. na dve mesti mačkam, ki tehtajo več kot 6,25 kg na spodnji del lobanje.
The product should be applied to dry skin in an area where the cat cannot lick it off.
Zdravilo je potrebno nanesti na suho kožo na mesto, kjer se mačka ne more polizati.
The product should be brought at room temperature (no more than 30 ºC) before use.
Zdravilo pred uporabo segrejte na sobno ali telesno temperaturo (ne nad 30 ºC).
The product should be brought to room or body temperature before use.
Zdravilo pred uporabo segrejte na sobno ali telesno temperaturo.
The product should be thrown away 21 days after first opening.
21 dni po prvem odprtju morate zdravilo zavreči.
The product should be used immediately after reconstitution.
Izdelek je treba po rekonstituciji nemudoma uporabiti, ker ne vsebuje konzervansa.
The product should be used immediately after reconstitution.
Zdravilo je treba po rekonstituciji nemudoma uporabiti, ker ne vsebuje konzervansa.
The product should not be administered at intervals shorter than 8 weeks as the safety at shorter intervals has not been tested.
Zdravila e ne smete dajati v manj kot 8-tedenskih razmikih, ker varnost za krajše razmike ni bila testirana.
The product should not be administered at intervals shorter than 8 weeks as the safety at shorter intervals has not been tested.
Zdravilo se ne sme dajati v manj kot 8-tedenskih razmikih, ker varnost za krajše razmike ni bila testirana.
The product should not be administered at intervals shorter than 8 weeks as the safety at shorter intervals has not been tested.
Zdravilo se ne sme dajati v razmikih, krajših od 8 tednov, ker varnost za krajše razmike ni bila testirana.
The product should not be administered at intervals shorter than 8 weeks as the safety for shorter intervals has not been tested.
Zdravilo se ne sme dajati v manj kot 8-tedenskih razmikih, ker varnost za krajše razmike ni bila testirana.
The product should not be injected.
Zdravila NEVANAC ne smete injicirati.
The product should not be placed in direct contact with certain types of bones.
Zdravilo ne sme biti v neposrednem stiku z določenimi kostmi.
The product should not be used if it has been dropped, or if it is visibly damaged.
Aplikacijskega sistema se ne sme uporabljati, če je padlo na tla ali je vidno poškodovano.
The product should not enter water courses as this may be dangerous for fish and other aquatic organisms.
Zdravilo ne sme priti v vodotoke, ker je lahko nevarno za ribe in druge vodne organizme.
The product should then be sprayed onto the surface of the tissue in short bursts (0.1-0.2 ml) to form a thin, even layer.
Zdravilo nato pršite na površino tkiva v kratkih razprških (0,1–0,2 ml), da nastane tanek, enakomeren sloj.
The product stimulates the development of active immunity against porcine circocvirus type 2 and
Cepivo vzbuja razvoj aktivne imunosti proti cirkovirusu prašičev tipa 2 in proti mikoplazmi
The product was administered to kittens at up to 5 times the recommended dose, every 2 weeks for 6 treatments, and there were no serious safety concerns.
Mačji mladiči, ki so dobivali petkratni terapevtski odmerek vsak drugi teden, po šestkratnem dajanju niso potrebovali pomoči.
The product was administered to puppies at up to 5 times the recommended dose, every 2 weeks for 6 treatments, and there were no serious safety concerns.
Pasji mladiči, ki so dobivali petkratni terapevtski odmerek vsak drugi teden, po šeskratnem dajanju niso potrebovali pomoči.
The product, when reconstituted, contains polysorbate-80, which is known to increase the rate of di-(2-ethylhexyl) phthalate (DEHP) extraction from polyvinyl chloride (PVC).
Pripravljena raztopina zdravila vsebuje polisorbat-80, ki dokazano poveča izluženje di-(2-etil- heksil)ftalata (DEHP) iz PVC-ja.
The production of factor IX in the body is controlled by the factor IX gene.
Nastajanje faktorja IX v telesu nadzira gen za faktor IX.
The product’s efficacy has not been tested in ferrets weighing over 2 kg and therefore the duration of effect might be shorter in these animals.
Testiranje učinkovitosti zdravila ni bilo opravljeno na belih dihurjih, težjih od 2 kg, zato je pri njih lahko učinkovanje zdravila krajše.
The profile of adverse reactions in the subgroup of patients with FL was consistent with the overall iNHL population.
Profil neželenih učinkov pri podskupini bolnikov s FL je bil skladen s celokupno populacijo iNHL.
The program shall teach the content of the mentioned educational material.
Program mora uporabnike seznaniti z vsebino omenjenega izobraževalnega programa.
The progression of disability was reduced in patients given Plegridy every two weeks but less clearly so in those given the medicines every four weeks.
Napredovanje nezmožnosti/invalidnosti je bilo zmanjšano tako pri bolnikih, ki so zdravilo Plegridy prejemali vsaka dva tedna, kot tudi pri bolnikih, ki so ga prejemali vsake štiri tedne.
The prolonged duration of action of Lantus is dependent on its injection into subcutaneous tissue.
Podaljšano delovanje zdravila Lantus je odvisno od tega, da je injiciran v podkožno tkivo.
The prolonged duration of action of Toujeo is dependent on its injection into subcutaneous tissue.
Podaljšano delovanje zdravila Toujeo je povezano s tem, da je injiciran v podkožno tkivo.
The prolonged effect of insulin glargine may delay recovery from hypoglycaemia.
Podaljšani učinek insulina glargina lahko upočasni okrevanje po hipoglikemiji.
The prolonged persistence and slow elimination from plasma (t1/2 = 12 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval.
Podaljšano zadrževanje in počasno izločanje iz plazme (t1/2 = 12 dni) in dejstvo, da ni ekstenzivnega metabolizma, zagotavljajo učinkovite koncentracije fluralanerja v času med dvema odmerkoma.
The prolonged- release tablet should not be divided.
Tablet s podaljšanim sproščanjem ne smete deliti.
The prolonged-release tablets are approximately 7 mm in diameter, debossed with V5 on one side and company symbol on the other side.
Tablete s podaljšanim sproščanjem s premerom približno 7 mm imajo na eni strani oznako V5, na drugi pa znak podjetja.
The prolonged-release tablets are approximately 7 mm in diameter, debossed with V5 on one side and the company logo on the other side.
Tablete s podaljšanim sproščanjem imajo premer približno 7 mm in imajo na eni strani oznako V5, na drugi pa znak podjetja.
The prolonged-release tablets are approximately 9 mm in diameter, debossed with V01 on one side and company symbol on the other side.
Tablete s podaljšanim sproščanjem s premerom približno 9 mm imajo na eni strani oznako V01, na drugi pa znak podjetja.
The prompt removal of faeces (within 12 hours) reduces the risk of transmission of infection.
Takojšnja odstranitev iztrebkov pred sporulacijo oocist (znotraj 12 ur) zmanjša možnost prenosa okužbe.
The proper patient management as regards the interaction with vaccination;
o pravilnem vodenju bolnikov glede medsebojnega delovanja s cepljenjem;
The proper patient management as regards the interaction with vaccination;
o ustreznem vodenju bolnikov glede interakcij s cepivi;
The prophylactic use of Budesonide/Formoterol Teva, e.g. before exercise, has not been studied.
Profilaktična uporaba zdravila Budezonid/formoterol Teva, na primer pred telesnim naporom, ni bila preučena.
The proportion of eltrombopag-treated patients with any bleeding (Grades 1-4) and clinically significant bleeding (Grades 2-4) was reduced from baseline by approximately 50% from Day 15 to the end of treatment throughout the 6 month treatment period.
V primerjavi z izhodiščem se je delež bolnikov s katerokoli krvavitvijo (stopnje 1-4) in klinično pomembno krvavitvijo (stopnje 2-4) med 6 mesečnim obdobjem od 15. dneva do konca zdravljenja z eltrombopagom zmanjšal za približno 50 %.
The proportion of enzalutamide-treated patients with measurable disease at baseline who had an objective soft tissue response was 58.8% (95% CI: 53.8, 63.7) compared with 5.0% (95% CI: 3.0, 7.7) of patients receiving placebo.
Delež bolnikov, zdravljenih z enzalutamidom, z merljivo boleznijo ob izhodišču, ki so imeli objektivni odziv mehkega tkiva, je bil 58,8 % (95-odstotni IZ: 53,8; 63,7) v primerjavi s 5,0 % (95-odstotni IZ: 3,0; 7,7) bolnikov, ki so dobivali placebo.